INTRODUCTION
Chemical modifications to nucleobases play important roles in mediating fundamental biological processes (Booth et al., 2015; Shu et al., 2018; Suzuki and Bird, 2008; Wu and Zhang, 2017) and are regarded as hallmarks of many diseases (Chen et al., 2017; Jackson and Bartek, 2009; Johnson et al., 2017) . Therefore, a detailed analysis of natural nucleobase modifications is essential for a complete understanding of genetic and epigenetic regulation (Hong et al., 2018; Iwan et al., 2017; Liu et al., 2016; Shen et al., 2014) . However, a global mapping of the modified nucleobases in the genome is often missing because of the low abundance of these modifications and lack of sensitive, selective, and genome-wide detection methods (Wyrick and Roberts, 2015) . , which is present in many cells and tissues (Hong and Wang, 2007; Pfaffeneder et al., 2014) , can be generated by exposure to UV light (Decarroz et al., 1986) , ionizing radiation (Hong and Wang, 2007; Kasai et al., 1990) , Fenton-type reagents, reactive oxygen species attack (Hong et al., 2006) , or enzyme oxidation (Pais et al., 2015) . It has been reported that 5fU modification can introduce gene mispairing (Yoshida et al., 1997) , alter DNA structures (Kawasaki et al., 2017b) , modulate protein-DNA interactions (Kittaka et al., 2001; Rogstad et al., 2004) , and induce perturbations of DNA function (Rogstad et al., 2004) . Recently, 5-formylcytosine (5fC), the modified cytosine counterpart of 5fU, has been identified as a vital epigenetic modification involved in gene regulation (Kitsera et al., 2017; Song et al., 2013; Wang et al., 2018b) , cell differentiation, and development (Wagner et al., 2015; Zhu et al., 2017) . 5fU may be an oxidation product of 5-hydroxymethyluracil (5hmU) in vivo, and 5hmU has been identified as not only an oxidized nucleobase but also an essential epigenetic mediator that influences transcription factors, changes the physical properties of local DNA duplex in the genome, and helps in binding of chromatin remodeling proteins (Kawasaki et al., 2017a (Kawasaki et al., , 2018 Modrzejewska et al., 2016; Pfaffeneder et al., 2014) . Whether 5fU also acts as an epigenetic mediator like 5fC and 5hmU remains an open question. Although many reagents such as aminothiophenol (Hirose et al., 2010) , phenylenediamine (Hardisty et al., 2015; Liu et al., 2017b; Wang et al., 2018a) , hydrazine (Kawasaki et al., 2017a; Liu et al., 2017a) , and indole (Samanta et al., 2015) derivatives have been utilized to selectively label 5fU, genome-wide profiling of 5fU remains a challenge owing to its low abundance in the genome. The development of an efficient, rapid, sensitive, environment-friendly, and catalyst-free method to analyze 5fU is highly desired.
Herein, we present a novel method termed fU-Seq for determining the genome-wide distribution of 5fU in mouse hippocampus and human thyroid carcinoma tissue via an azido-modified reagent that selectively labels 5fU (Figures 1A and 1B) . The challenge of selective capturing and profiling 5fU is therefore addressed by employing copper-free click chemistry between azido-modified 5fU-containing genomic DNA and commercial dibenzocyclooctyne (DBCO)-modified biotin (Click Chemistry Tools). After enrichment using streptavidin-coated magnetic beads, dithiothreitol can be used to cleave the biotin linker (Song et al., 2011) to release the pulled down 5fU-containing genomic DNA for further next-generation sequencing (NGS).
RESULTS

Evaluating the Reactivity of azi-BIAN with ODN-fU
First, we screened for chemicals that have the ability to efficiently tag 5fU with high yield and selectivity under warm conditions, when compared with other aldehyde modifications present in DNA. We successfully identified several chemicals that reacted efficiently with 5fU (Liu et al., 2017a (Liu et al., , 2017b (Liu et al., , 2018 . The inherent chemical properties of (2-benzimidazolyl)acetonitrile (azi-BIAN) make it high selectivity for 5fU in both nucleosides and oligonucleotides. More importantly, azi-BIAN could not react with abasic site and 5fC. We thus designed an azido derivative of azi-BIAN for enriching 5fU-containing genomic DNA (Schemes S1 and S2).
Next, we incubated a 15-mer oligodeoxyribonucleotide containing one 5fU site (ODN-5fU) with azi-BIAN in NaOAc buffer (pH 5.0) at 37 C for 6 hr. Complete conversion to the new product ODN-azi-biaU was recorded by reversed-phase (RP)-high-performance liquid chromatography (HPLC) (monitored at 260 nm) ( Figure 2C ). The integrity of labeled DNAs was confirmed by MALDI-TOF mass spectrometry (MS) (Figures 2D, S2A, and S2B) . In addition, enzymatically digested mononucleosides were analyzed through HPLC-MS to ensure that the reaction of 5fU yielded 5-formyl-2 0 -deoxyuridine and azi-BIAN adduct (azi-biaU) (Figure S3) . In control experiments, ODN-T, ODN-5hmU, ODN-5hmC, ODN-5fC, and ODN-AP (in which the 5fU site was replaced with a T, 5hmU, 5hmC, 5fC, and abasic site, respectively) were also selected to react with azi-BIAN under the same conditions. The high selectivity of azi-BIAN for 5fU was verified by RP-HPLC (monitored at 260 nm) ( Figure S1 ) and denaturing polyacrylamide gel electrophoresis analysis (Figures 2A and 2B) , indicating that the substitution of 5fU with 5fC or an abasic site containing aldehydes did not disturb selective labeling of 5fU by azi-BIAN. To manifest whether the oxidative damage occurs during (B) Schematic illustration of fU-Seq. Genomic DNA is fragmented, sequentially labeled with azi-BIAN, conjugated to biotin for pull-down enrichment, and released following enrichment using DTT to define 5fU sites throughout the genome. NGS, next-generation sequencing.
sample workup, ODN-5fC was incubated with azi-BIAN and then the mixture was subjected to DNA MALDI-TOF MS analysis. No mass spectra of ODN-azi-biaU appeared ( Figure S4B) . Meanwhile, the model DNA (80 bp double-stranded [ds] ODN-fC) was subjected to extraction by DNeasy Blood & Tissue Kit for simulating the process of genomic DNA extraction. After that, the extracted DNA was digested for liquid chromatography (LC)-MS analysis. No 5fU peaks was found ( Figure S5 ). These results indicated that the oxidative damage did not occur during sample workup.
Enriching 5fU-Containing DNA Fragments
Besides the advantage of 5fU selective labeling, the labeled 5fU containing biotin can be used to enrich DNA fragments bearing 5fU. Because most biological samples bearing 5fU are in ds form, it was also vital to determine whether azi-BIAN selectively labels 5fU in dsDNAs. Therefore, we used a series of 80 bp dsDNAs (containing two 5fC or 5fU sites per strand or only canonical nucleosides) as a test of specificity under conditions described previously (Hardisty et al., 2015) to evaluate the enrichment efficiency. These ODNs were made to react with azi-BIAN followed by biotinylation. fU-DNA was enriched over C-DNA by $157-fold with azi-BIAN, whereas fC-DNA was enriched over C-DNA by 1.1-fold, based on qPCR quantitation. These results confirmed that our pull-down method fU-Seq has specificity for enriching 5fU-containing DNA (Figure 2E) . Because of NaBH 4 can reduce 5fU to 5hmU and hydroxylamine (EtONH 2 ) can react with formyl group of 5fU, we applied the 80bp-dsDNA which contain 5fU was reduced by NaBH 4 or blocked by EtONH 2 as the control experiments to validate the effectively enrichment on model DNA containing 5fU (Figures S6 and S7) . Taken together, these experiments demonstrate that covalent chemical labeling coupled with biotin-based affinity purification ensures accurate and comprehensive capture of 5fU-containing DNA fragments. (C) RP-HPLC trace (260 nm) of ODN-5fU (black line); ODN-azi-biaU (blue line), which was generated by reaction with azi-BIAN; and ODN-azi-biaU, which was further labeled with DBCO-S-S-PEG3-bitoin (ODN-biotin-U, red line).
(D) MALDI-TOF-spectra of ODN-5fU, ODN-5fU after incubation with azi-BIAN, and ODN-5fU after incubation with azi-BIAN and reaction with DBCO-biotin.
(E) Enrichment tests of a single pool of spike-in amplicons containing 5fU, 5fC, or only canonical nucleobases, using fU-Seq. Values shown are fold enrichment over canonical nucleobases. Data are represented as mean G SD of biological triplicate.
Genome-wide Mapping of 5fU in Mouse Hippocampal Tissues
Recently, the LC-tandem MS (MS/MS) quantification results indicated that 5fU levels are slightly higher in mouse hippocampus (2310 À6 per nucleoside) than in other tissues (Pfaffeneder et al., 2014) . Thus, we performed selective labeling of 5fU in genomic DNA isolated from mouse hippocampus. Genomic DNA from mouse hippocampus was sonicated into small fragments ($250-450 base pairs), treated with azi-BIAN to yield azido-modified 5fU-containing genomic DNA, and labeled with DBCO-biotin to install biotin ( Figure 1B ). Because each step is bio-orthogonal and efficient, this protocol ensures selective labeling of most 5fU sites present in genomic DNA. The presence of the introduced biotin group was confirmed by avidin-horseradish peroxidase tagging and enhanced chemiluminescence visualization to obtain a dot in the dot blot assays ( Figure S8 ), and the HPLC-MS analyses of enzymatically digested mononucleosides from labeled genome DNA proved that the reaction of 5fU yielded the target product ( Figure S9 ).
Pull-down genomic DNA and an input control obtained from the same genomic DNA sample were subjected to high-throughput sequencing. We first removed adapter sequences in sequencing reads with cutadapt and only kept the reads with acceptable sequencing quality using FastQC to obtain clean data (version 0.11.5, Babraham Bioinformatics) (Martin, 2011) . Following these steps, Bowtie2 (version 1.2.1.1) (Langmead et al., 2009 ) was used to map the remaining reads to the reference genome of Mus musculus (GRCm38.p5.genome, downloaded from GENCODE) in single-end alignment mode.
To determine the pull-down efficiency, we identified the peaks with read enrichment in pull-down sample relative to the input control using HOMER (v4.9) software (Heinz et al., 2010) . Using the findPeaks command with default parameters, 42,954 peaks were found across the genome, of which 39,829 peaks remained after filtering with the following criteria: fold change of pull down versus control > 4 and p value of pull-down versus control < 10 À5 .
A chromosome-level analysis of 5fU-enriched peaks indicated that the 5fU sites occur in a near-uniform distribution, although their presence was relatively higher in chromosomes 1 (8.28%), 2 (7.26%), and 5 (6.82%) ( Figure S10 ). In consideration of the difference in chromosome size, a rather higher distribution in chrM (peak number/genome size = 1.23310 À4 ) and an extremely lower distribution in chrY (peak number/genome size = 3.27310 À8 ) were found ( Figure 3A ). The fold change versus control for most peaks (75%) was found to fall between 6.46 and 24.47 ( Figure 3B ). We further examined the distribution of 5fU sites within different genomic element groups and found that 62.12% of the sites occurred in intergenic regions, 36.02% in introns, and 1.87% in other regions, including promoters, transcriptional termination sites (TTSs), and exons ( Figure 3C ). Enriched peaks were inspected in the Integrative Genomics Viewer (IGV) (Robinson et al., 2011; Thorvaldsdó ttir et al., 2013) using the input control and pull-down data as shown in Figure 4A . We also obtained heatmaps of both the input and pull-down data ( Figure 4B ) with the script annotatePeaks.pl, from which the pull-down efficiency could be calculated. This result was also further confirmed by qPCR ( Figure S11 ). These results indicated that the selective enrichment of 5fU in genome by the fU-Seq strategy is effective.
To speculate the potential genetic significance of 5fU on histone modifications, with the annotatePeaks.pl (-size: 4,000; -hist: 10), several major existing histone modification peak data of brain tissues in adult M. musculus, including H3K27ac, H3K27me3, H3K4me1, and H3K4me3 (downloaded from ENCODE database), were compared with 5fU sites. Interestingly, the appearance of 5fU sites in the genome negatively correlated with H3K27ac modification peak but positively correlated with H3K27me3 modification peak ( Figures 4C and S12 ). H3K27me3 is known for preventing transcription. These two histone modifications have been reported to be physiologically antagonistic. When H3K27 is trimethylated, it is tightly associated with inactive gene promoters, whereas acetylation of H3K27 is associated with active transcription (Barski et al., 2007; Ferrari et al., 2014) . Thus, it is reasonable to speculate that 5fU sites might also play an inhibitory role in gene transcription. Also, more efforts need to be made for testifying this speculation.
Genome-wide Mapping of 5fU in Human Thyroid Carcinoma Tissues
With the advances of new techniques for whole-genome sequencing, carcinomas are discovered to be associated with modified nucleobases. Recently, researchers found that 5fU levels are about ten 5-formyldeoxyuridine per 10 6 nucleotides in human thyroid carcinoma tissues (Jiang et al., 2017) . So exploring the distribution of 5fU in cancer tissues might be vital for understanding the relationship between diseases and 5fU. Encouraged by the results of genome-wide mapping of 5fU in mouse hippocampal tissues, we further analyzed the distribution of 5fU in human thyroid carcinoma tissues. Similarly, the genomic DNA was fragmented to 250-450 bp, labeled with azi-BIAN, and biotinylated for enrichment. The pulldown samples are applied for library construction and NGS.
To verify if the methods of fU-Seq are reproducible, two biological replicates were prepared to validate the results. Input 1 (I1) and input 2 (I2) represented the input groups, and pull down 1 (P1) and pull down 2 (P2) represented the pull-down groups. The NGS reads were aligned to the reference human genome (GRCh38.p7, downloaded from GENCODE). After overlapping the two biological replicates, about 950 peaks were identified (Figures S13 and S14).
We next analyzed the distribution pattern of 5fU peaks along each chromosome ( Figure 5A ). The results show that the distribution of 5fU in human thyroid carcinoma tissues is uniform in most chromosomes. The fold change of pull-down versus control for most peaks (50%) was found to fall between 6.32 and 15.30 ( Figure 5B ). To locate 5fU sites within the genome, we examined the distribution of 5fU sites within different gene fragment groups and found that 54.17% of the sites occurred in intergenic segments and 43.02% in introns (Figures 5C and S15). We then examined whether 5fU is enriched at specific types of different genomic elements. We found that 5fU is highly enriched at low_complexity and simple_repeat but is depleted at transposable elements including long terminal repeats (LTRs), short interspersed nuclear elements, and long interspersed nuclear elements ( Figure S16 ). Enriched peaks were visualized in the IGV using the input control and pull-down data as shown in Figure 6A . To determine the pull-down efficiency, the heatmap results were obtained (Figures 6B and S17). We also validated the 5fU-specific enrichments observed in the peaks with qPCR ( Figure S18 ). All these results manifested that the selective enrichment of 5fU in genome by the fU-Seq strategy is effective. We further investigated whether 5fU in human thyroid carcinoma tissues is associated with histone modification or protein-binding sites, which has genetic significance. With the assistance of annotatePeaks.pl (-size: 4,000; -hist: 2), several major existing histone modification peak and protein-binding site data of thyroid gland tissues in adults, including H3K27ac, H3K27me3, H3K4me1, H3K4me3, POLR2A (all downloaded from ENCODE database), were compared with 5fU sites. Surprisingly, the appearance of 5fU sites in the genome negatively correlated with H3K4me1 modification peak, whereas it positively correlated with binding sites of POLR2A protein ( Figure 6C ). H3K4me1 is enriched at active enhancers and acts as a marker for many cell-type-specific enhancer sites (Creyghton et al., 2010; Rada-Iglesias, 2018; Shen et al., 2016) . Hence, it is tempting to speculate that 5fU sites in human thyroid carcinoma tissues are indicative of suppressed enhancer overactivation. Besides, a lot of researchers had reported that POLR2A encodes the largest and catalytic subunit of the RNA polymerase II complex (Bradner, 2015; Liu et al., 2015) . Because 5fU sites act as a potential repressor, they may be distributed around POLR2A-binding sites. It is reasonable to guess that the existence of 5fU in human thyroid carcinoma may impede protein binding with DNA and then inhibit the transcription of some specific genes. Further endeavor is needed for studying the causal relationship between 5fU and cancers.
DISCUSSION
The current study developed the first selective and efficient approach (fU-Seq) to label and capture 5fU from mouse and human genomic DNA and investigated the relationship between 5fU and histone modifications. We have demonstrated the feasibility of using this method to determine the genome-wide distribution of 5fU. Intriguingly, most 5fU sites were found in intergenic regions and introns. In addition, the analysis of histone modifications and 5fU sites suggested that 5fU might play an inhibitory role in gene transcription. Also, the distribution of 5fU in human thyroid carcinoma tissues is positively correlated with binding sites of POLR2A protein, which indicates that 5fU may distributed around POLR2A-binding Li et al., 2017) . Aldehydes present in 5fU are more active than 5fC (Habgood et al., 2011; Hardisty et al., 2015) , which might also conjugate histone to yield DNA-protein cross-linking and influence transcriptional regulation and chromatin remodeling. Although the method we proposed could not realize single-base-resolution analysis of 5fU, we believe that this goal can be realized in the future, according to the recent report of single-base-resolution detection method of 5hmU proposed by Balasubramanian's group (Kawasaki et al., 2018) . Further studying and applying this method will advance our understanding of the role played by 5fU modification in genomics.
Limitations of the Study
Although this method can profile the distribution of 5fU in genomic DNA, it does not have single-base resolution. In addition, it is unavoidable for nonspecific enrichment of DNA during pull-down process. We are currently in the process of realizing the single-base-resolution analysis of 5fU, as per the recent report by Balasubramanian's group (Kawasaki et al., 2018) . Combining with the single-base-resolution analysis, the nonspecific enrichment of DNA can be ruled out.
External Data
H3K27ac (ENCSR000CCE, ENCSR000CDC, ENCSR000CDD), H3K27me3 (ENCSR000CFM), H3K4me1 (ENCSR000CCF, ENCSR000CAL, ENCSR000CAI, ENCFF710BOL), H3K4me3 (ENCSR000CAK, ENCSR000-CAJ, ENCSR000CDS), and POLR2A (ENCFF079QGD) chromatin immunoprecipitation sequencing datasets were obtained from ENCODE Project database.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file. The average distribution of merged 5fU peak (the peaks in pull-down 1 was merged with the peaks in pull-down 2) calculated from two biological replicates normalized to chromosome size in whole-genome level, using two sets of input data (I1 and I2) as control, respectively. (B) Box chart showing the distribution of four sets of 5fU peaks calculated from two pull-down data (P1, P2) and two input data (I1, I2) based on fold change versus control. C is the maximum value, -is minimum value, A is mean, the box stands for interquality (25-75%) area, the line within is median, upper split line is 90% point, and lower split line is 10% point. I1, input 1; I2, input 2; P1, pull-down 1; P2, pull-down 2.
(C) Percentage of 5fU peak lengths overlapping with genomic features.
DATA AND SOFTWARE AVAILABILITY
Sequencing data have been deposited into the Gene Expression Omnibus (GEO). The accession number is GSE115918. Wang, Y., Liu, C., Yang, W., Zou, G., Zhang, X., Wu, F., Yu, S., Luo, X., and Zhou, X. (2018a). Naphthalimide derivatives as multifunctional molecules for detecting 5- 
SUPPLEMENTAL INFORMATION
Chr
Peak ID Gene Name PCR-Primer(5'-3') Chr1 Chr1-41 4931408C2 0Rik Co., Ltd. Wuhan, China). The modified nucleotide was incorporated at the designed sites with the synthesized phosphoramidites using our previous report. Purified oligonucleotides were characterized by mass spectra. 80-bp dsDNAs (containing 5fC or 5fU sites) were obtained by incorporation dfUTP or dfCTP during the process of PCR amplification. Shorter oligonucleotides containing 5fC were purchased from Takara Biotechnology (Dalian, China). General oligonucleotides and primers were synthesized and purified from GeneCreate Co., Ltd. Wuhan, China. dfCTP and dfUTP were purchased from Trilink Biotechnologies.
Genomic DNA extraction. The adult mice were bought from Hubei Research Center of Laboratory Animals. The tissues were picked out under the image of Nikon SMZ1500 Microscope followed by washing with 1× PBS three times. The human thyroid carcinoma tissues were collected from Hubei Cancer Hospital. Genomic DNAs were extracted and purified by DNeasy® Blood & Tissue Kit (Qiagen, Germany) according to the manufacturer's instructions. 5fU labeling and click chemistry. Generally, 5fU labeling reaction can be divided into two steps.
Firstly, ODNs containing 5fU were performed in 100 mM NaOAc buffer (pH 5.0) with 12.5 mM azi-BIAN (self-synthesized) at 37℃ for 6 hr in a 1.5 mL tube in a thermo-shaker (Ningbo Biocotek Scientific Instrument Co., Ltd., China, 1500 r.p.m.). After purification with the mini quick spin oligo column (Roche), DBCO-S-S-PEG3-biotin (Click Chemistry Tools, A112-10) was added into the system for click reaction to a final concentration of 20 mM and incubated at 37℃ for 2 hr in a thermo-shaker (1500 r.p.m. Enzymatic of labeled 5fU. To verify the successful reaction between azi-BIAN and ODN-5fU, the labeled DNA was digested to use LC-MS for testing the product. Typically, DNAs and degradase plus
(1 μL, 5U/μL) (Zymo Research) were mixed in 1× degradase plus reaction buffer in a final volume of 25 μL at 37℃ for 2 hr. Then filtered by an ultrafiltration tube (3 kDa cutoff, Amicon, Millipore) to remove the enzymes followed by LC-MS assay.
Biotin labeling of 5fU in genomic DNA samples. Genomic DNA was fragmented by sonication with
Covaris sonicator under the condition of 175 W for 7 min (Thermo Fisher) to obtain 250 to 450 bp fragments. Typically, 30 μg fragmented genomic DNAs were added into the mixture of 5 μL NaOAc-HOAc buffer (1 M, pH 5.0) and 5 μL azi-BIAN (100 mM in DMSO) and then added H 2 O to get a final volume of 50 μL. After concussion and centrifugation, the mixture was incubated at 37℃ for 10 hr in a thermo-shaker (Ningbo Biocotek Scientific Instrument Co., Ltd., China, 1500 r.p.m.). Then the excess chemicals were removed by the mini quick spin oligo column (Roche).
DBCO-S-S-PEG3-biotin (Click Chemistry Tools, A112-10) was added into the purified product at 37℃ for 2 hr for click chemistry to form the biotin labeling of 5fU in genomic DNA. After that the mixture was purified by the mini quick spin oligo column (Roche) for further enrichment. Each sample test was repeated three times independent. The mixture was subject to qPCR according to the protocol by the manufacturer's instructions. DNA concentration was quantified by comparison with calibration lines of known concentration of input ODNs.
Dot-blot assay. Synthesized model DNA or genomic DNA was treated using biotin-labeling protocol as described above. For the dot-blot assay, different DNAs were spotted on Amersham Hybond-N+ membrane (GE Healthcare). After dried, the membrane was UV-crosslinked with 254 nm at RT for 5 min twice and then washed with 1× TBST twice. Then the membrane was blocked with 5% BSA at 37 ℃ for 1 hr and washed with 1× TBST five times. After incubation with streptavidin-HRP (1:1500) (Thermo Scientific) at 37℃ for 1 hr and washed with 1× TBST four times, the results were visualized by enhanced chemiluminescence (SuperSignal™ West Pico Chemiluminescent Substrate, Cat: 34077, Thermo Scientific) using Molecular Imager® ChemiDocTM XRS+ Imaging System (Bio-Rad). Finally, the membrane was soaked in methylene blue (in NaOAc buffer) to verify the existence of DNA of every dot.
Library preparation and next-generation sequencing of labeled 5fU-enriched DNA samples. The fU-Seq enriched genomic DNAs were quantified using a Qubit Fluorometer (Thermo). Then the DNAs were used directly for library preparation with a Thruplex DNA-Seq kit (Rubicon Genomics) according to the manufacturer's instructions. AMPure XP beads (Beckman) were used for library purification.
The purified libraries were subjected into NGS using Hiseq PE150. A pair-end sequencing mode was suggested for maximal data collection. Each biological sample was prepared replicates in parallel, two non-labeled input DNAs (input: pre-fU-Seq), two enriched by pull-down output samples (output:
fU-Seq enriched genomic DNA) were sequenced according to the same procedure.
Sequencing data processing and analysis. Raw data were first analyzed with FastQC (Version 0.11.5, Babraham Bioinformatics) to check out the overall sequencing quality, followed with trimming for residual adapter sequence at 3' end and bases whose sequencing quality score were lower than 28 using cutadapt. Processed reads were then mapped to the mouse genome (Mus musculus, GRCm38.p5.genome.fa, downloaded from GENCODE database) by Bowtie2 (version 1.2.1.1).
Mapping results can be obtained through the options -N 1 -L 20 in both paired-end and single-end modes. The 5fU-enriched regions in each output file were detected using HOMER (v4.9) findPeaks algorithm, and a total 42954 peaks were found. After screening all peaks with standards of fold change of pull-down vs control > 4 and p-value < 10 -5 , there remains 39829 peaks. Peak annotation analysis was done using HOMER annotatePeaks algorithm while reads visualization was done with Integrative Genomics Viewer (IGV) under the help of SAMtools (Li et al., 2009 ) and bedtools (Quinlan and Hall, 2010) . To plot the distribution of fU-Seq signals around 5fU sites more accurately, we ignored the sites located within anshul.blacklist.mm10.bed and psublacklist.mm10.bed (downloaded from ENCODE database). To study the relationship between 5fU sites and histone modification, annotatePeaks algorithm of HOMER was used with options -size 4000 -hist 10.
Synthesis
Scheme S1: Synthesis of azide modified (2-benzimidazolyl)acetonitrile derivative (azi-BIAN) 3,4-diaminobenzoic acid (3 g, 19.7 mmol) and ethyl cyanoacetate (7 mL, 65.8 mmol) were dispersed in 100 mL round bottom flask. Then, the reaction mixture was kept stirring and stayed at 180°C. After 1 hr, the reaction mixture was poured into 100 mL diethyl ether, the precipitate was filtered off and purified by silica gel chromatography, eluting with 1% methanol and 0.1% acetic acid in (Refaat, 2010) .
BIAN (290 mg, 1.4 mmol), 3-azidopropan-1-amine (720 mg, 7.2 mmol) (Schatz et al., 2009 ) and HATU (1.1 g, 2.9 mmol) were dissolved into 10 mL DMF which containing 5 drops of TEA in 25 mL round bottom flask. Then, the reaction mixture was kept stirring and stayed at 25°C . After 4 hr, the reaction mixture was evaporated under vacuum and purified by silica gel chromatography, eluting with dichloromethane: methanol from 100:1 to 40:1 to give azi-BIAN (yield 80%) as a white solid. 
Scheme S2: Synthesis of 5-formyl-2'-deoxyuridine and azi-BIAN adduct (azi-biaU)
5-formyl-2'-deoxyuridine (30 mg, 0.12 mmol) and azi-BIAN (33 mg, 0.12 mmol) were dissolved into 10 mL methanol which containing 5 drops of acetic acid in 25 mL round bottom flask. Then, the reaction mixture was kept stirring and stayed at 50°C . After 15 hr, the reaction mixture was evaporated under vacuum and purified by silica gel chromatography, eluting with dichloromethane: methanol from 50:1 to 15:1 to give the product azi-biaU (yield 80%) as a yellow solid. 04, 162.12, 149.76, 143.38, 142.24, 138.00, 129.33, 129.22, 123.61, 122.02, 118.71, 116.68, 111.55, 107.86, 100.39, 88.68, 86.20, 71.21, 61.86, 49.06, 40.78, 37.22, 28. 
